NSE ScannerAgri, Sugar & Edible Oils · Agricultural Commodities/Milling · NSE: SHEEL · data 2026-10-31
Sheel Biotech Limited
In plain words
Price: 30.9% below its 52-week high of ₹82.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹110 cr |
| Net profit (last 12 months) | ₹12 cr |
| Sales growth, 3 years (yearly) | 11.2% |
| Profit growth, 3 years (yearly) | 32.3% |
At a glance
P/E 9.8, P/B 0.9, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 11.2%, ROCE 14.3%, operating margin 13.8%: how much profit it earns on the money it uses.
Debt/equity 0.07, Profit growth 32.3% and sales growth 11.2% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Profit grew 32.3% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Sheel Biotech Limited debt-free?
Its latest reported debt-to-equity ratio is 0.07, which is very low.
What is Sheel Biotech Limited's P/E ratio?
About 9.8, based on the last 12 months' earnings and a price of ₹56.65 (data 2026-10-31).
What is the 52-week high and low of Sheel Biotech Limited?
The 52-week high is ₹82 and the 52-week low is ₹37.8.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Sheel Biotech Limited | ₹56.65 | ₹115 cr | 9.8 | 0.9 | 11.2% | 14.3% | 0.07 | -29.2% |
| Dollex Agrotech Limited | ₹36.6 | ₹144 cr | 18.4 | — | 8.9% | 6% | 1.33 | -8.5% |
| B & A Limited | ₹375 | ₹128 cr | 159.3 | — | -2.8% | 2.7% | 0.81 | -14.6% |
| TBI Corn Limited | ₹68.55 | ₹124 cr | 6.8 | 1 | 16.8% | 27.7% | 0.59 | -23.0% |
| Vishwaraj Sugar Industries Ltd. | ₹4.69 | ₹102 cr | — | 0.5 | -10.6% | -6.5% | 1.66 | -41.4% |
| ShreeOswal Seeds & Chemicals Ltd. | ₹10.9 | ₹100 cr | 8.2 | — | 15.2% | 27.8% | 1.21 | -28.2% |
Compare SHEEL with DOLLEX in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SHEEL in NSE Scanner →